论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Sparcl1 与动脉粥样硬化
Authors Cheng X , Chen X, Zhang M, Wan Y, Ge S , Cheng X
Received 3 February 2023
Accepted for publication 3 May 2023
Published 17 May 2023 Volume 2023:16 Pages 2121—2127
DOI https://doi.org/10.2147/JIR.S406907
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Tara Strutt
Abstract: Atherosclerosis and its complications constitute some of the major diseases affecting humans worldwide. A core component of atherogenesis is endothelial cell damage and dysfunction, which also includes factors such as adhesion and proliferation of various cells. Multiple studies have shown that atherosclerosis and cancer share a common pathophysiological process and exhibit a degree of similarity. Sparcl-1 is a cysteine-rich secretory stromal cell protein present in the extracellular matrix and belongs to the Sparc family of proteins. Its role in tumor development has been widely investigated; however, its role in cardiovascular diseases has rarely been studied. Sparcl-1 is considered an oncogene correlated with the regulation of cell adhesion, migration, and proliferation and is also related to blood vessel integrity. In this review, the potential link between Sparcl-1 and atherosclerosis development is investigated, and recommendations on future research on the role of Sparcl-1 in atherogenesis are provided.
Keywords: Sparcl-1, atherogenesis, cancer